Chemomab Therapeutics Ltd. Operating Lease, Liability, Noncurrent
Chemomab Therapeutics Ltd. (CMMB) had Operating Lease, Liability, Noncurrent of $0 as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-03-23
- 2025-12-31: Operating Lease, Liability, Noncurrent $0.00.
- 2025-06-30: Operating Lease, Liability, Noncurrent $0.00.
- 2024-12-31: Operating Lease, Liability, Noncurrent $209.00K.
- 2024-06-30: Operating Lease, Liability, Noncurrent $251.00K.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-03-23 | |
| 2025-06-30 | $0.00 6-K · filed 2025-08-14 | |
| 2024-12-31 | $209.00K 20-F · filed 2026-03-23 | |
| 2024-06-30 | $251.00K 6-K · filed 2024-08-21 | |
| 2023-12-31 | $316.00K 20-F · filed 2025-04-04 | |
| 2023-06-30 | $33.00K 6-K · filed 2023-08-14 | |
| 2023-03-31 | $62.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $91.00K 20-F · filed 2024-03-28 | |
| 2022-09-30 | $118.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $148.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $203.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $237.00K 10-K · filed 2023-03-20 | |
| 2021-09-30 | $298.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $320.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $328.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $358.00K 10-K · filed 2022-03-30 | $16.00K 10-K · filed 2021-03-09 |
| 2020-09-30 | $63.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $108.00K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $152.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $725.00K 10-K · filed 2021-03-09 |